| - SMTL ID
- 5sf9.1
- Ligands
- ZINC ION; MAGNESIUM ION; 2-methyl-3-{[(4R)-1-methyl-4-phenyl-4,5-dihydro-1H-imidazol-2-yl]methoxy}quinoxaline
- Polypeptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
- Oligo-state
- monomer
|
| - SMTL ID
- 5sf9.2
- Ligands
- ZINC ION; MAGNESIUM ION; 2-methyl-3-{[(4R)-1-methyl-4-phenyl-4,5-dihydro-1H-imidazol-2-yl]methoxy}quinoxaline
- Polypeptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
- Oligo-state
- monomer
|
| - SMTL ID
- 5sf9.3
- Ligands
- ZINC ION; MAGNESIUM ION; 2-methyl-3-{[(4R)-1-methyl-4-phenyl-4,5-dihydro-1H-imidazol-2-yl]methoxy}quinoxaline
- Polypeptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
- Oligo-state
- monomer
|
| - SMTL ID
- 5sf9.4
- Ligands
- ZINC ION; MAGNESIUM ION; 2-methyl-3-{[(4R)-1-methyl-4-phenyl-4,5-dihydro-1H-imidazol-2-yl]methoxy}quinoxaline
- Polypeptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
- Oligo-state
- monomer
|